You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

Details for Patent: 9,629,821


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,629,821 protect, and when does it expire?

Patent 9,629,821 protects OMEGAVEN and is included in one NDA.

This patent has five patent family members in four countries.

Summary for Patent: 9,629,821
Title:Treatment and prevention of liver disease associated with parenteral nutrition (PN)
Abstract: The present invention is based on the discovery that parenteral nutrition (PN) induced liver disease, e.g. fatty liver disease, can be prevented and even reversed by administration of primarily omega-3-fatty acid with PN rather than the administration of the standard intravenous lipid emulsions that contain primarily plant derived omega-6 fatty acid. Thus, the present invention provides a method for treating or preventing liver disease in a human patient obtaining nutritional support through PN. The method comprises intravenous administration of an effective amount of an omega-3-fatty acid emulsion to the patient, wherein the patient is not administered phytosterols or plant derived fatty acids, e.g. omega-6 fatty acids derived from a plant source, and wherein the administration of the omega-3-fatty acid emulsion to the patient is for a period greater than three weeks. Preferably, the administration is for a period of greater than six weeks. More preferably, the administration is for a period greater than three months.
Inventor(s): Puder; Mark (Medfield, MA), Gura; Kathleen M. (Norfolk, MA)
Assignee: Childrens Medical Center Corporation (Boston, MA)
Application Number:12/165,785
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 9,629,821: A Comprehensive Guide

Introduction

When analyzing a patent, understanding its scope and claims is crucial for determining its validity, enforceability, and potential impact on the market. This article will delve into the specifics of United States Patent 9,629,821, providing a detailed analysis of its scope and claims, and contextualizing it within the broader patent landscape.

Understanding Patent Scope and Claims

Before diving into the specifics of Patent 9,629,821, it is essential to understand what patent scope and claims entail.

Patent Scope

Patent scope refers to the breadth and depth of protection granted by a patent. It is often measured using metrics such as independent claim length and independent claim count, as discussed in research papers on patent quality[3].

Patent Claims

Patent claims are the legal definitions of the invention and define the scope of the protection granted by the patent. They are typically categorized into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims.

United States Patent 9,629,821: Overview

To analyze Patent 9,629,821, one must first identify the key elements of the patent, including its title, abstract, and claims.

Title and Abstract

The title and abstract provide a brief overview of the invention. For example, if the patent is titled "Method and System for [Specific Invention]," the abstract would summarize the main aspects of the method or system.

Claims

The claims section is the most critical part of the patent as it defines the legal boundaries of the invention. Here, you would look at both the independent and dependent claims to understand what is specifically protected.

Conducting a Detailed Analysis

Step-by-Step Strategy

To conduct a detailed analysis, follow these steps:

1. Identify the Independent Claims

Independent claims are the cornerstone of the patent and define the invention in its broadest terms. Analyze these claims to understand the core aspects of the invention.

2. Examine Dependent Claims

Dependent claims further limit the independent claims and provide additional details about the invention. These claims can help in understanding the specific embodiments and variations of the invention.

3. Review the Description and Drawings

The description and drawings section provides detailed explanations and visual representations of the invention. This section can help clarify any ambiguities in the claims.

4. Analyze Prior Art and Citations

Using tools like the Common Citation Document (CCD) or the Patent Public Search tool, identify prior art and citations related to the patent. This helps in understanding how the patent differs from existing inventions and its position within the patent landscape[1].

Tools and Resources for Analysis

Several tools and resources are available to aid in the analysis of a patent.

Patent Public Search

The Patent Public Search tool, provided by the USPTO, offers enhanced access to prior art and allows users to search through a vast database of patents and published patent applications[1].

Global Dossier

The Global Dossier service provides access to the file histories of related applications from participating IP Offices, which can be crucial for understanding the global context of the patent[1].

Common Citation Document (CCD)

The CCD application consolidates prior art cited by all participating offices for the family members of a patent application, making it easier to visualize the search results on a single page[1].

International Patent Landscape

Understanding the international patent landscape is essential for assessing the global impact and validity of a patent.

Searching International Patent Offices

Databases such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO) offer free online access to patent collections, allowing users to see if their idea has been patented abroad[1].

Legal and Policy Considerations

The legal and policy environment surrounding patents can significantly impact their scope and claims.

Small Claims Patent Court

Studies and discussions around the establishment of a small claims patent court highlight the need for more accessible and cost-effective dispute resolution mechanisms, which could influence how patents are enforced and their scope interpreted[2].

Metrics for Measuring Patent Scope

Research has identified simple metrics to measure patent scope, such as independent claim length and independent claim count. These metrics can provide insights into the breadth and clarity of the patent claims[3].

Independent Claim Length and Count

Studies have shown that narrower claims at publication are associated with a higher probability of grant and a shorter examination process. The examination process often narrows the scope of patent claims, indicating that the duration of examination can significantly impact the final scope of the patent[3].

Key Takeaways

  • Patent Scope and Claims: Understanding the scope and claims of a patent is crucial for determining its validity and market impact.
  • Tools and Resources: Utilize tools like Patent Public Search, Global Dossier, and CCD to analyze the patent and its position within the patent landscape.
  • International Landscape: Consider the global context by searching international patent offices.
  • Legal and Policy: Be aware of legal and policy considerations, such as the potential for a small claims patent court.
  • Metrics: Use metrics like independent claim length and count to measure the breadth and clarity of patent claims.

FAQs

Q: How do I conduct a preliminary U.S. patent search?

A: You can conduct a preliminary U.S. patent search using the Patent Public Search tool, which provides enhanced access to prior art. Additionally, resources like the Global Dossier and CCD can be helpful[1].

Q: What are the key elements of a patent that I should analyze?

A: The key elements include the title, abstract, claims (both independent and dependent), and the description and drawings section.

Q: How do I measure the scope of a patent?

A: Metrics such as independent claim length and independent claim count can be used to measure the scope of a patent. These metrics have explanatory power for several correlates of patent scope[3].

Q: What is the significance of the Global Dossier service?

A: The Global Dossier service provides access to the file histories of related applications from participating IP Offices, helping users understand the global context of the patent[1].

Q: Why is it important to consider the international patent landscape?

A: Considering the international patent landscape helps in understanding if the idea has been patented abroad and in assessing the global impact and validity of the patent[1].

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court
  3. SSRN - Patent Claims and Patent Scope: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. USA.gov - U.S. Patent and Trademark Office (USPTO): https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  5. United States Courts - Report on Filing Patent/Trademark: https://www.uscourts.gov/forms-rules/forms/report-filing-patent-trademark

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,629,821

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Fresenius Kabi Usa OMEGAVEN fish oil triglycerides EMULSION;INTRAVENOUS 210589-001 Jul 27, 2018 RX Yes Yes 9,629,821 ⤷  Subscribe Y USE FOR PATIENTS WITH PARENTERAL NUTRITION ASSOCIATED CHOLESTASIS OR PARENTERAL NUTRITION ASSOCIATED LIVER DISEASE ⤷  Subscribe
Fresenius Kabi Usa OMEGAVEN fish oil triglycerides EMULSION;INTRAVENOUS 210589-002 Jul 27, 2018 RX Yes Yes 9,629,821 ⤷  Subscribe Y USE FOR PATIENTS WITH PARENTERAL NUTRITION ASSOCIATED CHOLESTASIS OR PARENTERAL NUTRITION ASSOCIATED LIVER DISEASE ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,629,821

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2004289353 ⤷  Subscribe
Australia 2011201893 ⤷  Subscribe
Canada 2545752 ⤷  Subscribe
European Patent Office 1684739 ⤷  Subscribe
World Intellectual Property Organization (WIPO) 2005046669 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.